Canada markets closed

Lifecore Biomedical, Inc. (LFCR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.20-0.07 (-1.33%)
At close: 04:00PM EDT
5.15 -0.05 (-0.96%)
After hours: 04:04PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 158.84M
Enterprise Value 252.38M
Trailing P/E N/A
Forward P/E 8.97
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.51
Price/Book (mrq)1.57
Enterprise Value/Revenue 2.44
Enterprise Value/EBITDA -13.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 3-36.59%
S&P500 52-Week Change 323.76%
52 Week High 311.46
52 Week Low 34.50
50-Day Moving Average 36.09
200-Day Moving Average 36.88

Share Statistics

Avg Vol (3 month) 3223.88k
Avg Vol (10 day) 3143.67k
Shares Outstanding 530.55M
Implied Shares Outstanding 630.55M
Float 816.89M
% Held by Insiders 16.25%
% Held by Institutions 175.80%
Shares Short (May 15, 2024) 42.06M
Short Ratio (May 15, 2024) 414.68
Short % of Float (May 15, 2024) 49.75%
Short % of Shares Outstanding (May 15, 2024) 46.73%
Shares Short (prior month Apr 15, 2024) 41.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends May 28, 2023
Most Recent Quarter (mrq)May 28, 2023

Profitability

Profit Margin -96.41%
Operating Margin (ttm)-7.68%

Management Effectiveness

Return on Assets (ttm)-4.67%
Return on Equity (ttm)-104.52%

Income Statement

Revenue (ttm)103.27M
Revenue Per Share (ttm)3.45
Quarterly Revenue Growth (yoy)20.80%
Gross Profit (ttm)N/A
EBITDA -9.92M
Net Income Avi to Common (ttm)-64.24M
Diluted EPS (ttm)-2.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.09M
Total Cash Per Share (mrq)0.62
Total Debt (mrq)177.52M
Total Debt/Equity (mrq)505.94%
Current Ratio (mrq)2.39
Book Value Per Share (mrq)-0.14

Cash Flow Statement

Operating Cash Flow (ttm)-17.44M
Levered Free Cash Flow (ttm)15.96M